WitrynaIMCOR Pharmaceutical is a Healthcare/Medical Equipment & Supplies company based in San Diego, California. Use the CB Insights Platform to explore IMCOR Pharmaceutical's full profile. IMCOR Pharmaceutical - Products, Competitors, Financials, Employees, Headquarters Locations WitrynaIMCOR shall at its own expense keep in force during the term of this Agreement as well as for a period of ten years thereafter adequately funded self-insurance or policies of …
IMCOR Pharmaceutical - Products, Competitors, Financials, …
WitrynaAMENDED AND RESTATED SUPPLY AGREEMENT . THIS AMENDED AND RESTATED SUPPLY AGREEMENT (“Agreement”) dated as of October 8, 2003, is by and between Genzyme Corporation, with principal offices located at One Kendall Square, Cambridge, Massachusetts 02139 ("Vendor") and Photogen Technologies, Inc., … WitrynaPatents Assigned to Imcor Pharmaceutical Company Methods and apparatus for monitoring and quantifying the movement of fluid. Patent number: 7081092 Abstract: Methods, systems and devices are provided for monitoring and quantifying the movement of fluid in a target region. Generally, an imaging agent is introduced into a target … how much snow in tahoe
Patents Assigned to Imcor Pharmaceutical Company - Justia …
Witryna27 lip 2005 · 3 - Specification and Quality Control Standards; GMP Compliance. 3.1 The quantities of the Material to be supplied hereunder shall be manufactured by Vendor in accordance with all applicable laws, rules and regulations, and in conformity with the specification and quality control standards set forth in Exhibit "B" attached hereto … WitrynaThis Exclusive Distribution Agreement (“Agreement”) is made as of April 1, 2002 (the “Effective Date”), between Alliance Pharmaceutical Corp., a New York corporation, having its principal place of business at 0000 Xxxxxxx Xxxx Xxxx, Xxx Xxxxx, Xxxxxxxxxx 00000 (“Client”), and CORD Logistics, Inc., an Ohio corporation, having its principal … WitrynaImcor Pharmaceutical Company: Compositions and methods for delivering pharmaceutically active agents using nanoparticulates AU2003230885A1 (en) 2002-04-12: 2003-10-27: Elan Pharma International Ltd. Nanoparticulate megestrol formulations US9101540B2 (en) * 2002-04-12: 2015-08-11: Alkermes Pharma Ireland Limited how do union shops and agency shops differ